AXDXUnknown
Accelerate Diagnostics, Inc Insider Trading Activity
Every SEC Form 4 insider transaction reported for Accelerate Diagnostics, Inc (AXDX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are AXDX insiders buying or selling?
Accelerate Diagnostics, Inc insiders reported no open-market purchases or sales in the last 12 months. Since February 2018, Trabud has recorded 132 Form 4 filings for AXDX: 73 buys ($45.4M) and 59 sells ($2.7M).
Source: SEC EDGAR Form 4
Key Statistics (February 2018 – Apr 7, 2025)
Total Form 4 filings
132
SEC EDGAR
Insider filers
12
Insider buys (73)
$45.4M
Insider sells (59)
$2.7M
Insider sentiment
Net buyingNet insider flow of $42.7M in net buying since February 2018.
Recent AXDX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Apr 7, 2025 | Jack Phillips | Chief Executive Officer | Sale | 25.3K | $0.65 | $16.5K | SEC ↗ |
| Apr 7, 2025 | Larry Michael Mertz | Chief Technology Officer | Sale | 1.5K | $0.65 | $989.95 | SEC ↗ |
| Apr 2, 2025 | David Patience | Chief Financial Officer | Sale | 6.8K | $0.71 | $4.8K | SEC ↗ |
| Feb 28, 2025 | David Patience | Chief Financial Officer | Sale | 535 | $1.09 | $583.15 | SEC ↗ |
| Feb 4, 2025 | Jack Phillips | Chief Executive Officer | Sale | 485 | $1.35 | $654.75 | SEC ↗ |
| Dec 4, 2024 | PATIENCE JOHN | Director | Purchase | 200.0K | $1.57 | $314.0K | SEC ↗ |
| Dec 4, 2024 | Jack W Schuler | Director, 10% Owner | Sale | 200.0K | $1.57 | $314.0K | SEC ↗ |
| May 21, 2024 | Larry Michael Mertz | Chief Technology Officer | Sale | 361 | $0.88 | $317.68 | SEC ↗ |
| Apr 18, 2024 | Jack Phillips | Chief Executive Officer | Sale | 26.7K | $0.78 | $20.9K | SEC ↗ |
| Apr 16, 2024 | Jack Phillips | Chief Executive Officer | Sale | 26.5K | $0.86 | $22.8K | SEC ↗ |
| Apr 10, 2024 | David Patience | Chief Financial Officer | Sale | 13.3K | $0.87 | $11.6K | SEC ↗ |
| Apr 10, 2024 | Larry Michael Mertz | Chief Technology Officer | Sale | 14.0K | $0.87 | $12.2K | SEC ↗ |
| Apr 5, 2024 | Larry Michael Mertz | Chief Technology Officer | Sale | 978 | $0.88 | $860.64 | SEC ↗ |
| Apr 5, 2024 | Jack Phillips | Chief Executive Officer | Sale | 15.9K | $0.88 | $14.0K | SEC ↗ |
| Feb 27, 2024 | David Patience | Chief Financial Officer | Sale | 350 | $0.96 | $336 | SEC ↗ |
| Feb 2, 2024 | Jack Phillips | Chief Executive Officer | Sale | 494 | $1.30 | $642.2 | SEC ↗ |
| Jan 25, 2024 | Strobeck Matthew | Director | Purchase | 100.0K | $0.00 | $0 | SEC ↗ |
| Jan 25, 2024 | Louise Francesconi | Director | Purchase | 13.3K | $0.00 | $0 | SEC ↗ |
| Jan 25, 2024 | Hany Massarany | Director | Purchase | 16.7K | $0.00 | $0 | SEC ↗ |
| Jan 25, 2024 | PATIENCE JOHN | Director | Purchase | 16.7K | $0.00 | $0 | SEC ↗ |
| Dec 14, 2023 | Jack Phillips | Chief Executive Officer | Sale | 739 | $4.39 | $3.2K | SEC ↗ |
| Dec 14, 2023 | David Patience | Chief Financial Officer | Sale | 97 | $4.39 | $425.83 | SEC ↗ |
| Nov 14, 2023 | Jack Phillips | Chief Executive Officer | Sale | 745 | $5.58 | $4.2K | SEC ↗ |
| Nov 14, 2023 | David Patience | Chief Financial Officer | Sale | 97 | $5.57 | $540.29 | SEC ↗ |
| Oct 16, 2023 | David Patience | Chief Financial Officer | Sale | 96 | $5.83 | $559.68 | SEC ↗ |
Showing the 25 most recent of 132 Form 4 filings for Accelerate Diagnostics, Inc.
Most active AXDX insiders
- Jack W Schuler56 filings
- Jack Phillips26 filings
- David Patience13 filings
- Steven Reichling13 filings
- Larry Michael Mertz8 filings
Ask anything about AXDX insider activity
Use Trabud's AI agent to query Accelerate Diagnostics, Inc's Form 4 history in plain English — "Show me AXDX CEO purchases this year" or compare it against any other ticker.
Open the AI agentAXDX insider trading FAQ
Are Accelerate Diagnostics, Inc insiders buying or selling?
Accelerate Diagnostics, Inc insiders reported no open-market purchases or sales in the last 12 months. Since February 2018, Trabud has recorded 132 Form 4 filings for AXDX: 73 buys ($45.4M) and 59 sells ($2.7M). Over the full record that is net buying of $42.7M.
How many insiders trade AXDX stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Accelerate Diagnostics, Inc. The most recent filing was accepted on Apr 7, 2025.
Where does Trabud get AXDX insider trading data?
All AXDX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.